Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Nov 17 - Nov 22
According to an IQVIA article, by mid-2025, GLP-1s made up more than half of all diabetes prescriptions and 23% of all first-line starts (up from 3% in 2021), displacing metformin and other cheaper generics that historically start the diabetes treatment journey
This pricing dynamic has created concerns about the long-run sustainability of the U.S
That got scientist thinking, maybe this is about more than just food cravings
23 Some studies demonstrated possible anti-inflammatory benefits from semaglutide use in patients with insulin resistance and psoriasis
This unexpected side effect led to further studies
Edgar RC
US$ 28.52
US$ 22.02
US$ 21.34
US$ 29.67
US$ 22.80
US$ 26.94
US$ 28.24
